XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 1,812,483      
Balance at Dec. 31, 2019 $ 182 $ 87,437,661 $ (89,723,016) $ (2,285,173)
Share-based compensation 512,719 512,719
Net loss (3,370,282) (3,370,282)
Issuance of common stock pursuant to securities purchase agreements (in shares) 87,500      
Issuance of common stock pursuant to securities purchase agreements $ 8 1,032,492 1,032,500
Commitment fee adjustment (900,000) (900,000)
Beneficial conversion feature 641,215 641,215
Issuance of common stock pursuant to warrant conversion (in shares) 121,500      
Issuance of common stock pursuant to warrant conversion $ 12 1,457,988 1,458,000
Conversion of convertible note payable (in shares) 288,461      
Conversion of convertible note payable $ 29 1,499,971 1,500,000
Deemed dividends related to down-round features 112,686 (112,686)
Balance (in shares) at Mar. 31, 2020 2,309,944      
Balance at Mar. 31, 2020 $ 231 91,794,732 (93,205,984) (1,411,021)
Balance (in shares) at Dec. 31, 2020 7,814,572      
Balance at Dec. 31, 2020 $ 782 119,844,026 (99,509,689) 20,335,119
Issuance of common stock for directors’ fees (in shares) 2,091      
Issuance of common stock for directors’ fees 7,510 7,510
Legal and commitment fees (2,709) (2,709)
Issuance of restricted common stock to employees (in shares) 1,250      
Issuance of restricted common stock to employees
Share-based compensation 133,638 133,638
Net loss (851,431) (851,431)
Balance (in shares) at Mar. 31, 2021 7,817,913      
Balance at Mar. 31, 2021 $ 782 $ 119,982,465 $ (100,361,120) $ 19,622,127